1. OPUS at UTS

Browsing byAuthorOliver, BG

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 212  next >
Issue DateTitleAuthor(s)
2021-01-20A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38Li, J; Xie, Y; Zhao, P; Qin, Y; Oliver, BG; Tian, Y; Li, S; Wang, M; Liu, X
2022-03-24A comparison of attitudes towards remote learning during the COVID-19 pandemic between students attending a Chinese and an Australian campus.Chen, H; Van Reyk, D; Reyna, J; Oliver, BG
2021-08A narrative review of clinical studies of herbal treatment of difficult to manage asthma.Li, H; Chen, H; Morgan, L; Li, W; Oliver, BG
2020-12A phospholipid-based formulation for the treatment of airway inflammation in chronic respiratory diseasesKomalla, V; Allam, VSRR; Kwok, PCL; Sheikholeslami, B; Owen, L; Jaffe, A; Waters, SA; Mohammad, S; Oliver, BG; Chen, H; Haghi, M
2016-04-01Absence of back to school peaks in human rhinovirus detections and respiratory symptoms in a cohort of children with asthmaStelzer-Braid, S; Tovey, ER; Willenborg, CM; Toelle, BG; Ampon, R; Garden, FL; Oliver, BG; Strachan, R; Belessis, Y; Jaffe, A; Reddel, HK; Crisafulli, D; Marks, GB; Rawlinson, WD
2024-07Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.Huang, D; Zhang, L; Liu, Y; Wang, J; Zhang, J; Baines, KJ; Liu, G; Hsu, AC-Y; Wang, F; Chen, Z; Oliver, BG; Xie, M; Qin, L; Liu, D; Wan, H; Luo, F; Li, W; Wang, G; Gibson, PG
-Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseasesGulati, N; Chellappan, DK; MacLoughlin, R; Gupta, G; Singh, SK; Oliver, BG; Dua, K; Dureja, H
2022-07-01Adverse roles of mast cell chymase-1 in chronic obstructive pulmonary disease.Liu, G; Jarnicki, AG; Paudel, KR; Lu, W; Wadhwa, R; Philp, AM; Van Eeckhoutte, H; Marshall, JE; Malyla, V; Katsifis, A; Fricker, M; Hansbro, NG; Dua, K; Kermani, NZ; Eapen, MS; Tiotiu, A; Chung, KF; Caramori, G; Bracke, K; Adcock, IM; Sohal, SS; Wark, PA; Oliver, BG; Hansbro, PM
2023-01Age-Related Clinical Characteristics, Inflammatory Features, Phenotypes, and Treatment Response in Asthma.Wang, J; Zhang, X; Zhang, L; Liu, Y; Wang, G; Zhang, HP; Wang, L; Kang, DY; Oliver, BG; Wan, HJ; McDonald, VM; Chen-Yu Hsu, A; Liu, D; Li, WM; Birring, SS; Wang, G
2022-02-17Aim2 suppresses cigarette smoke-induced neutrophil recruitment, neutrophil caspase-1 activation and anti-Ly6G-mediated neutrophil depletion.Donovan, C; Kim, RY; Galvao, I; Jarnicki, AG; Brown, AC; Jones-Freeman, B; Gomez, HM; Wadhwa, R; Hortle, E; Jayaraman, R; Khan, H; Pickles, S; Sahu, P; Chimankar, V; Tu, X; Khadem Ali, M; Mayall, JR; Nguyen, DH; Budden, KF; Kumar, V; Schroder, K; Robertson, AA; Cooper, MA; Wark, PA; Oliver, BG; Horvat, JC; Hansbro, PM
2017-12-01Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1cLiu, G; Cooley, MA; Nair, PM; Donovan, C; Hsu, AC; Jarnicki, AG; Haw, TJ; Hansbro, NG; Ge, Q; Brown, AC; Tay, H; Foster, PS; Wark, PA; Horvat, JC; Bourke, JE; Grainge, CL; Argraves, WS; Oliver, BG; Knight, DA; Burgess, JK; Hansbro, PM
2021-04-15Airway smooth muscle cells from severe asthma patients with fixed airflow obstruction are responsive to steroid and bronchodilator treatment in vitroRutting, S; Xenaki, D; Reddy, KD; Baraket, M; Chapman, DG; King, GG; Oliver, BG; Tonga, KO
2015-01-01Altered Innate Immune Responses in Neutrophils from Patients with Well- and Suboptimally Controlled AsthmaTang, FSM; Foxley, GJ; Gibson, PG; Burgess, JK; Baines, KJ; Oliver, BG
2019-11-01Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosisMoodley, YP; Corte, TJ; Oliver, BG; Glaspole, IN; Livk, A; Ito, J; Peters, K; Lipscombe, R; Casey, T; Tan, DBA
2020-08-20Animal and translational models of SARS-CoV-2 infection and COVID-19.Johansen, MD; Irving, A; Montagutelli, X; Tate, MD; Rudloff, I; Nold, MF; Hansbro, NG; Kim, RY; Donovan, C; Liu, G; Faiz, A; Short, KR; Lyons, JG; McCaughan, GW; Gorrell, MD; Cole, A; Moreno, C; Couteur, D; Hesselson, D; Triccas, J; Neely, GG; Gamble, JR; Simpson, SJ; Saunders, BM; Oliver, BG; Britton, WJ; Wark, PA; Nold-Petry, CA; Hansbro, PM
2023-07Anoverview of biomedical applications for gold nanoparticles against lung cancerKumari, V; Vishwas, S; Kumar, R; Kakoty, V; Khursheed, R; Babu, MR; Harish, V; Mittal, N; Singh, PK; Alharthi, NS; Hakami, MA; Aba Alkhayl, FF; Gupta, G; Rubis, GD; Paudel, KR; Singh, M; Zandi, M; Oliver, BG; Dua, K; Singh, SK
2022-05-26Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies.Wilder, BK; Vigdorovich, V; Carbonetti, S; Minkah, N; Hertoghs, N; Raappana, A; Cardamone, H; Oliver, BG; Trakhimets, O; Kumar, S; Dambrauskas, N; Arredondo, SA; Camargo, N; Seilie, AM; Murphy, SC; Kappe, SHI; Sather, DN
2018-07-01Apoptosis signal-regulating kinase 1 inhibition attenuates human airway smooth muscle growth and migration in chronic obstructive pulmonary diseaseEapen, MS; Kota, A; Vindin, H; McAlinden, KD; Xenaki, D; Oliver, BG; Deshpande, DA; Sohal, SS; Sharma, P
-Applications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseasesChan, Y; Prasher, P; Löbenberg, R; Gupta, G; Singh, SK; Oliver, BG; Chellappan, DK; Dua, K
-Applications of extracellular vesicles as a drug-delivery system for chronic respiratory diseasesManandhar, B; Paudel, KR; Panth, N; Hansbro, P; Oliver, BG; Dua, K
Showing results 1 to 20 of 212  next >